Healthcare | January 09, 2026
Leeford Healthcare bets Rs. 200 crore on orthopedic & mobility aids
Tiger Shroff fronts ‘Fit Raho, Hit Raho’ campaign
Tiger Shroff fronts ‘Fit Raho, Hit Raho’ campaign
The therapy was well tolerated through Week 24, with a safety profile consistent with Alumis’ Phase 2 data
Pembrolizumab has shown meaningful benefit only when combined with chemotherapy
Singh previously served as Head of IT (Development and Manufacturing Services) at Syngene International Limited, Lead of IT Manufacturing at UPL, and AGM at The Hi-Tech Gears
The study will run across 18 sites and enroll roughly 200 patients over 24 months
The drug, currently in a phase 1b/2 clinical trial for small cell lung cancer, is a polymer nanoparticle formulation of SN-38
Singlera and Pure Medical will team up with local universities, hospital networks, and national healthcare systems across Western Europe for research studies
Full approval will depend on verification of clinical benefit in a confirmatory trial
NUFYMCO BLA has been approved by the USFDA
The Phase 3 HER2CLIMB-05 trial showed a 35.9% reduction in risk for patients treated with TUKYSA
Subscribe To Our Newsletter & Stay Updated
